SUMMER 2026 I HEALTH SYSTEM • INFUSION
28
Q. What is a 503B outsourcing facility,
and how does it differ from traditional
compounding pharmacies?
503B outsourcing facilities play a distinct and important
role in the healthcare ecosystem. As FDA-registered
entities operating under current Good Manufacturing
Practices (cGMP), they are held to a higher standard
of quality, consistency, and oversight compared to
traditional 503A compounding pharmacies. Unlike
503A pharmacies, which prepare patient-specific
prescriptions, 503B facilities produce medications in
advance for healthcare providers, enabling both scale
and standardization.
Q. When should hospitals consider using a
503B outsourcing facility?
Hospitals often turn to 503B outsourcing facilities when
they are balancing increasing clinical demand with
limited pharmacy resources. Whether driven by drug
shortages, staffing constraints, or the need for ready-to-
administer medications, 503Bs can help extend internal
capabilities. Increasingly, they are viewed not just as
supplemental resources, but as part of a broader strategy
to ensure consistent access to critical medications.
Q. How do 503B outsourcing facilities
support drug shortage mitigation?
Drug shortages remain a persistent challenge, and 503B
facilities play a key role in helping to mitigate their
impact. By producing medications listed on the FDA
Drug Shortage List and maintaining available inventory,
503Bs can respond more quickly to supply disruptions.
This proactive approach helps healthcare providers
avoid gaps in therapy and maintain continuity of care.
Q. What quality and regulatory standards do
503B facilities follow?
Quality is foundational to the 503B model. These facilities
operate under cGMP requirements, which encompass
rigorous controls around sterility assurance, environmental
monitoring, batch testing, and documentation. Regular
FDA inspections and required reporting further reinforce
accountability. Leading 503B organizations also invest
in robust quality systems and infrastructure to drive
consistency and maintain a high level of confidence in
their products.
BARB KNIGHTLY, PHARMD, RPH, CHIEF QUALITY OFFICER, LEITERS HEALTH
QUESTION & ANSWER
503B
FACILITIES &